Givaudan stock
Price history
+22.58% over the period1 year: from CHF 3,322.00 (November 17, 2025) to CHF 4,072.00 (November 17, 2026), +22.58%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 17, 2026 | CHF 4,072.00 |
| October 30, 2026 | CHF 3,973.00 |
| September 30, 2026 | CHF 3,410.00 |
| August 31, 2026 | CHF 3,282.00 |
| July 31, 2026 | CHF 3,230.00 |
| June 30, 2026 | CHF 3,420.00 |
| May 29, 2026 | CHF 2,900.00 |
| April 30, 2026 | CHF 2,785.00 |
| March 31, 2026 | CHF 2,684.00 |
| February 27, 2026 | CHF 3,092.00 |
| January 30, 2026 | CHF 2,988.00 |
| December 30, 2025 | CHF 3,146.00 |
| November 28, 2025 | CHF 3,387.00 |
| November 17, 2025 | CHF 3,322.00 |
At a glance
The company
Manufacture and supply of fragrance, beauty, taste and wellbeing products for the consumer goods industry
Latest results
Quarter to September 30, 2026
Next event
TickerLandia's take on Givaudan
- Priced as usual relative to earnings: P/E on the latest fiscal year 35 vs a median of 33 over its last 10 fiscal years.
- Priced in line with similar companies: trailing 12-month P/E 40 vs 41 (−2%) in a group of 10.
- Strong point: Market momentum (86/100 in its group). Weak point: Growth (29/100).
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−1.57% from the 52-week high
Analysts · 18 analysts
Average targetCHF 3,732.92−8.33% vs. price
Buy 7 · Hold 9 · Sell 2 · Hold
TickerLandia Fingerprint: Givaudan
Compared with similar companies: very strong momentum and very high price.
Financials and price compared with 59 companies in the specialty chemicals industry, worldwide. Momentum and risk compared with 1,160 European stocks.
Pricevery high81
How much it costs relative to what it produces.
Metric Value Position in group EV/EBITDA 26.8 85 P/E (trailing 12 months) 39.8 66 Forward P/E 30.3 85 Price/book 8.58 89 Price/sales 5.10 83 Profitabilityhigh78
How much it earns on revenue and capital.
Metric Value Position in group Gross margin 43.7% 75 Net margin 12.9% 82 ROE 22.3% 86 ROA 7.1% 69 Operating margin 17.9% 81 Earnings stabilityhigh69
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 1.5% 72 Loss-making yearscounts in reverse: lower means more earnings stability 0 of 5 annual reports 65 Growthlow29
How fast revenue and earnings are growing.
Metric Value Position in group Average revenue growth (3 years) +1.64% 60 Revenue growth (year over year) −1.70% 4 Earnings growth (year over year) −20.00% 23 Financial strengthlow36
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Net debt/EBITDAcounts in reverse: lower means more financial strength 2.27 40 Current ratio 1.29 19 Debt/equitycounts in reverse: lower means more financial strength 1.11 11 Interest coverage 13.1 74 Dividendaverage57
How much it returns to shareholders, and for how long.
Metric Value Position in group Consecutive dividend years 26 years 61 Dividend yield 1.8% 41 Payout ratio 70.1% 68 Market momentumvery strong86
How the stock has moved compared with the market.
Metric Value Position in group Relative strength (3 months) +18.13% 93 Relative strength (6 months) +31.47% 94 1-year return +20.43% 62 Distance from 200-day average +27.55% 95 Riskaverage53
How much the price swings.
Metric Value Position in group Volatility (60 days) 26.9% 50 Beta (1 year) 0.93 66 Maximum drawdown (12 months) 22.4% 43
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 17, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Givaudan is priced as in the past and in line with similar companies
On the latest fiscal year's earnings (2025), Givaudan's P/E today is 35.3, in line with the median of its last 10 fiscal years (32.8; between 26.9 and 54.2 from 2016 to 2025). Givaudan's P/E (trailing 12 months): 39.8, in line with the median of a group of 10 similar companies (40.8).
Compared with 10 similar companies
| Metric | Givaudan | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 39.8 | Middle | |
| Forward P/E | 30.3 | High | |
| Operating margin | 17.9% | Middle | |
| ROE | 22.3% | High | |
| Debt/equity | 1.11 | High |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Givaudan. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
CHF 3.8B
Latest quarter · Q2 2026
Net income
CHF 475M
Latest quarter · Q2 2026
Quarterly net margin
12.5%
Latest quarter · Q2 2026
Numbers and valuation
Full valuation- Market cap
- CHF 37.77B
- P/E
- 39.8
- EPS
- CHF 102.70
- Volume
- 8.92K
- Daily trading
- €63.81M
- Dividend yield
- 1.77%
- Last ex-dividend on March 23, 2026
How Givaudan is changing
All resultsRevenue grew 3.4% a year on average over the last 5 years
Operating margin rose from 15.4% to 18.3%
Profits turn into cash: free cash flow equal to 125% of net income
Returns
Givaudan returns with dividends
CHF 1,000 invested in Givaudan 5 years ago, on November 17, 2021, would be worth CHF 999 today with dividends reinvested: −0.10% in total, −0.02% per year. On price alone it would be CHF 902 (−9.75%).
| Period | Givaudan | SMI | CHF 1,000 becomes |
|---|---|---|---|
| 1 month | +2.65% | +4.53% | CHF 1,026 |
| 6 months | +50.81% | +13.61% | CHF 1,508 |
| Year to date | +29.43% | +13.20% | CHF 1,294 |
| 1 year | +25.90% | +19.22% | CHF 1,259 |
| 3 years | +34.09% | +39.88% | CHF 1,341 |
| 5 years | −0.10% | +19.20% | CHF 999 |
| 10 years | +184.12% | +88.57% | CHF 2,841 |
Over the last 6 months it has done better than 92% of the stocks in the Consumer sector.
From 1 year up with dividends reinvested, before taxes; under a year price only. SMI: price only. Calculate your investment
The chart in detail
Givaudan: technical analysis
Givaudan is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 15.7% below its all-time closing high (CHF 4,830.00, December 16, 2021).
- Trend
- Upward
- RSI (14 sessions)
- 67
- Between 30 and 70
- vs 200-session average
- +26.73%
Support and resistance
Price areas where Givaudan has stopped several times in the last year. They describe the chart; they are not forecasts.
- No resistance above: the price is near the highs of the year
- Last priceCHF 4,072.00
- SupportCHF 3,425.00−15.89%3 touches, last on August 26, 2026
- SupportCHF 3,325.00−18.34%2 touches, last on October 2, 2026
- SupportCHF 3,219.50−20.94%4 touches, last on February 24, 2026
Volatility and risk
Over the last year it has moved roughly in line with the SMI.
- Beta (1 year) vs SMI
- 0.92
- Volatility (60 sessions, annualised)
- 27.0%
- Largest fall in the last year
- −22.44%
Close of November 17, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Givaudan: seasonality
Average monthly price change over 27 years
Over the last 27 years, the strongest month for Givaudan has been June: +18.91% on average, positive in 16 years out of 27. The weakest has been March: −0.50% on average, positive in 12 years out of 27. November, the current month, has been positive in 17 years out of 26 (+1.38% on average).
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | −0.47% | +0.13% | 14 of 27 |
| February | −0.10% | +0.86% | 14 of 27 |
| March | −0.50% | −0.37% | 12 of 27 |
| April | +3.49% | +2.57% | 22 of 27 |
| May | +0.71% | +1.30% | 16 of 27 |
| June | +18.91% | +0.75% | 16 of 27 |
| July | +0.59% | +0.81% | 15 of 27 |
| August | +0.40% | +1.14% | 18 of 27 |
| September | +0.10% | +0.86% | 15 of 27 |
| October | +1.19% | +1.10% | 17 of 27 |
| November | +1.38% | +0.76% | 17 of 26 |
| December | +1.50% | +2.19% | 20 of 27 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Givaudan and its competitors
Fragrances and flavours are the products people most often associate with Givaudan, which creates fine fragrances and supplies fragrance ingredients, active beauty products, and household and laundry care items.
- Headquarters
- Vernier, Switzerland
- Employees
- 17,508
- Founded
- 1796
- Chief executive
- Christian Stammkoetter
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| GivaudanGIVN | $44.95B | 17.9% | 39.8 | +50.81% |
| SikaSIKA | $36.15B | 13.6% | 29.2 | +36.68% |
| NovozymesNSIS.B | $30.93B | 23.4% | 41.4 | +19.35% |
| DSM-FirmenichDSFIR | $27.97B | 6.8% | — | +56.97% |
| EMS-CHEMIE HOLDINGEMSN | $23.83B | 29.9% | 42.3 | +26.96% |
| Air LiquideAI | $134.69B | 19.7% | 34.6 | +19.17% |
Same industry or related industries, similar size. Compare Givaudan with its competitors · Full profile
